PM
Paul A Mahon (EVP & GENERAL COUNSEL) filed 24 Form 4 reports in the trailing twelve months (0 purchases, 24 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $5.5M of UTHR (10,742 sh across 4 lots, as filed), executed Dec 24 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
24
0 buys · 24 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$98.2M
shares × price, as filed
Last traded
Nov 5
Filed Nov 5
Median ADV $265.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $170.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
24 filings
Sector per market data · by filing · past 12 months
Most traded names
UTHRRecent filings
UTHRSALE
United Therapeutics Corporation
View filing →
$4.3M7,983 sh across 9 lots
Exec Jun 18
Filed Jun 18 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.5M
8,300 sh across 8 lots
Exec Jun 4
Filed Jun 4 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.6M
8,180 sh across 8 lots
Exec May 21
Filed May 21 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.8M
8,150 sh across 6 lots
Exec May 7
Filed May 7 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.8M
8,300 sh across 5 lots
Exec Apr 16
Filed Apr 16 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.7M
8,300 sh across 11 lots
Exec Apr 2
Filed Apr 2 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.4M
8,220 sh across 6 lots
Exec Mar 19
Filed Mar 19 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $3.9M
8,100 sh across 8 lots
Exec Mar 5
Filed Mar 5 · 5:30 PM ET More filings →